SOM Biotech was selected to present at the 2017 New York Venture Summit in front of more than 100 top tier VCs, Corporate VCs and Angel Investors. New York, July 18th-19th, 2017.

Dr. Raúl Insa, SOM Biotech CEO, and Michael Greenberg, VP Business Development, were attending this relevant financing event.

Further information at NY Venture Summit